Deutsche Bank Ag\ Profound Medical Corp. Transaction History

Deutsche Bank Ag\

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$16.0 - $20.59 $59,200 - $76,183	-3,700 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$19.16 - $28.09 $641,860 - $941,015	-33,500 Reduced 90.05%	3,700 $74,000
Q4 2020 Feb 16, 2021	BUY	$16.4 - $22.9 $477,239 - $666,390	29,100 Added 359.26%	37,200 $765,000
Q3 2020 Nov 12, 2020	BUY	$14.05 - $18.13 $99,755 - $128,723	7,100 Added 710.0%	8,100 $143,000
Q2 2020 Aug 13, 2020	SELL	$9.41 - $16.94 $4,705 - $8,470	-500 Reduced 33.33%	1,000 $17,000
Q1 2020 May 14, 2020	BUY	$6.88 - $19.7 $1,032 - $2,955	150 Added 11.11%	1,500 $15,000
Q4 2019 Feb 14, 2020	BUY	$6.4 - $11.95 $8,640 - $16,132	1,350 New	1,350 $14,000

8.93M

1.2K

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $157M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.